← Top storiesPolicy● Neutral for Indian equitiesUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues1 source · first seen 03:22 3 Oct · updated 03:22 3 OctTags on this storyPick a tag to see all its storiesNovo Nordisk1 todayUSFDA2 todayPharma and healthcare12 todayRead the reports1 report · earliest 03:22ReutersUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues03:22